IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer

JOURNAL ARTICLE published February 2022 in Cancer Letters

Research funded by National Natural Science Foundation of China (81671711,81972500,82171981)

Authors: Ri Sa | Rui Liang | Xian Qiu | Ziyan He | Zhiyan Liu | Libo Chen